AU2015233583B2 - New polymorphs and new solid states of Tiacumicin B - Google Patents

New polymorphs and new solid states of Tiacumicin B Download PDF

Info

Publication number
AU2015233583B2
AU2015233583B2 AU2015233583A AU2015233583A AU2015233583B2 AU 2015233583 B2 AU2015233583 B2 AU 2015233583B2 AU 2015233583 A AU2015233583 A AU 2015233583A AU 2015233583 A AU2015233583 A AU 2015233583A AU 2015233583 B2 AU2015233583 B2 AU 2015233583B2
Authority
AU
Australia
Prior art keywords
tiacumicin
crystal
xrpd
solvate
crystal solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015233583A
Other languages
English (en)
Other versions
AU2015233583A1 (en
Inventor
Stefan Kluge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Xellia Pharmaceuticals ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals ApS filed Critical Xellia Pharmaceuticals ApS
Publication of AU2015233583A1 publication Critical patent/AU2015233583A1/en
Application granted granted Critical
Publication of AU2015233583B2 publication Critical patent/AU2015233583B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AU2015233583A 2014-03-18 2015-03-17 New polymorphs and new solid states of Tiacumicin B Active AU2015233583B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461954715P 2014-03-18 2014-03-18
US61/954,715 2014-03-18
US201462020570P 2014-07-03 2014-07-03
US62/020,570 2014-07-03
PCT/EP2015/055531 WO2015140153A1 (en) 2014-03-18 2015-03-17 New polymorphs and new solid states of tiacumicin b

Publications (2)

Publication Number Publication Date
AU2015233583A1 AU2015233583A1 (en) 2016-09-15
AU2015233583B2 true AU2015233583B2 (en) 2019-04-11

Family

ID=52697399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015233583A Active AU2015233583B2 (en) 2014-03-18 2015-03-17 New polymorphs and new solid states of Tiacumicin B

Country Status (17)

Country Link
US (1) US10227371B2 (https=)
EP (1) EP3119793B1 (https=)
JP (1) JP2017507994A (https=)
KR (1) KR20160134719A (https=)
CN (1) CN106103462A (https=)
AU (1) AU2015233583B2 (https=)
BR (1) BR112016021542B1 (https=)
CA (1) CA2940902C (https=)
DK (1) DK3119793T3 (https=)
ES (1) ES2668351T3 (https=)
HR (1) HRP20180668T1 (https=)
HU (1) HUE038426T2 (https=)
IL (2) IL247726A0 (https=)
PL (1) PL3119793T3 (https=)
PT (1) PT3119793T (https=)
SI (1) SI3119793T1 (https=)
WO (1) WO2015140153A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108727387B (zh) * 2018-07-25 2021-03-16 天津大学 依鲁替尼乙酸异丙酯溶剂化合物及其制备方法
CN109053738B (zh) * 2018-08-29 2020-10-16 浙江工业大学 一种依鲁替尼的溶剂化物及其制备方法
CN114224899B (zh) * 2020-09-09 2024-04-26 首都医科大学附属北京胸科医院 非达霉素用于制备抑制脓肿分枝杆菌活性的产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091554A1 (en) * 2007-01-22 2008-07-31 Optimer Pharmaceuticals, Inc. Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
WO2013170142A1 (en) * 2012-05-10 2013-11-14 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
WO2004014295A2 (en) 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production
CN102614207B (zh) * 2005-01-31 2016-01-13 默克夏普&多梅有限公司 18元环大环化合物及其类似物
ZA200905337B (en) 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
ITMI20120560A1 (it) 2012-04-05 2013-10-06 Olon Spa Procedimento per la purificazione della tiacumicina b
US8722863B2 (en) 2012-05-10 2014-05-13 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091554A1 (en) * 2007-01-22 2008-07-31 Optimer Pharmaceuticals, Inc. Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
WO2013170142A1 (en) * 2012-05-10 2013-11-14 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof

Also Published As

Publication number Publication date
PL3119793T3 (pl) 2018-07-31
BR112016021542A2 (https=) 2017-08-15
US10227371B2 (en) 2019-03-12
PT3119793T (pt) 2018-05-10
SI3119793T1 (en) 2018-06-29
EP3119793A1 (en) 2017-01-25
DK3119793T3 (en) 2018-05-22
BR112016021542B1 (pt) 2023-01-31
KR20160134719A (ko) 2016-11-23
IL265180B (en) 2022-01-01
US20170081355A1 (en) 2017-03-23
HUE038426T2 (hu) 2018-10-29
CN106103462A (zh) 2016-11-09
WO2015140153A1 (en) 2015-09-24
IL265180A (en) 2019-05-30
CA2940902C (en) 2022-10-25
HRP20180668T1 (hr) 2018-06-15
CA2940902A1 (en) 2015-09-24
ES2668351T3 (es) 2018-05-17
EP3119793B1 (en) 2018-03-14
JP2017507994A (ja) 2017-03-23
IL247726A0 (en) 2016-11-30
AU2015233583A1 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
WO2007127292A2 (en) Tigeycline crystalline forms and processes for preparation thereof
KR102576964B1 (ko) 헤테로시클리덴 아세트아미드 유도체의 결정
IL265180A (en) New polymorphs and new solid states of thiacomycin b
US20210292479A1 (en) Solid state forms of sugammadex sodium
CN106892900A (zh) 一种富马酸沃诺拉赞及其制备方法
EP4034256B1 (en) Solid state forms of lucerastat salts and process for preparation thereof
WO2020082061A1 (en) Solid state forms of voclosporin
WO2012010092A1 (zh) 一种肽类物质的晶体及其制备方法和用途
WO2024180474A1 (en) Solid state forms of sabizabulin and process for preparation thereof
CN103755609A (zh) 酒石酸沃尼妙林的新晶型及其制备方法
WO2018078383A1 (en) Pharmaceutical composition comprising amorphous selexipag
CN107163025A (zh) 一种治疗消化系统疾病的药物化合物及其制备方法
WO2021216628A1 (en) Solid state forms of trifarotene and process for preparation thereof
AU2015341341A1 (en) Crystal forms of verapamil hydrochloride
ES3040339T3 (en) Solid state forms of at-001 and process for preparation thereof
CN110256515A (zh) 多拉菌素晶型a、晶型b及其制备方法
ES2984774T3 (es) Procedimiento para la preparación de compuestos orgánicos férricos
KR102150825B1 (ko) 새로운 sglt-2 억제제의 신규한 공결정
WO2024069574A1 (en) Solid state forms of denifanstat
WO2025141467A1 (en) Solid state forms of lorundrostat and process thereof
WO2025078973A1 (en) Solid state forms of linerixibat and process for preparation thereof
CN121021607A (zh) 环维黄杨星d盐型制品的制备方法及应用
EP4547654A1 (en) Solid state forms of paltusotine and process for preparation thereof
WO2025158416A1 (en) Solid state forms of elacestrant and processes for preparation thereof
EP4051659A1 (en) Solid state forms of fezagepras and process for preparation thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)